RBC-derived vesicles as a systemic delivery system of doxorubicin for lysosomal-mitochondrial axis-improved cancer therapy

Killing cancer cells by rupturing their lysosomes

(2020) Jichuan Qiu et al.   Nature Nanotechnology

Targeted crystallization of mixed-charge nanoparticles in lysosomes induces selective death of cancer cells

(2020) Magdalena Borkowska et al.   Nature Nanotechnology

Typical and Atypical Inducers of Lysosomal Cell Death: A Promising Anticancer Strategy

(2018) Antoni Domagala et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis

(2017) Benny Zhitomirsky et al.   Oncotarget

Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems

(2016) Carlos H. Villa et al.   ADVANCED DRUG DELIVERY REVIEWS

An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCL

(2016) Y. Mai et al.   BLOOD

Lysosomes as mediators of drug resistance in cancer

(2016) Benny Zhitomirsky et al.   DRUG RESISTANCE UPDATES

Drug delivery by erythrocytes: “Primum non nocere”

(2016) Carlos H. Villa et al.   TRANSFUSION AND APHERESIS SCIENCE

Nanocarriers for cancer-targeted drug delivery

(2015) Preeti Kumari et al.   JOURNAL OF DRUG TARGETING

Inorganic Phosphate Prevents Erk1/2 and Stat3 Activation and Improves Sensitivity to Doxorubicin of MDA-MB-231 Breast Cancer Cells

(2015) Luigi Sapio et al.   MOLECULES

Cell or Cell Membrane-Based Drug Delivery Systems

(2015) Songwei Tan et al.   Theranostics

Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance

(2015) Benny Zhitomirsky et al.   Oncotarget

Lysosomal membrane permeabilization in cell death: Concepts and challenges

(2014) Urška Repnik et al.   MITOCHONDRION

Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes

(2013) Weiwei Gao et al.   ADVANCED MATERIALS

Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications

(2012) Randall Logan et al.   Expert Opinion on Drug Metabolism & Toxicology

Versatile RBC-derived vesicles as nanoparticle vector of photosensitizers for photodynamic therapy

(2012) Leng-Yin Wang et al.   Nanoscale

Role of oxidative stress in lysosomal membrane permeabilization and apoptosis induced by gentamicin, an aminoglycoside antibiotic

(2011) Sophie Denamur et al.   FREE RADICAL BIOLOGY AND MEDICINE

Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

(2011) C.-M. J. Hu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Doxorubicin-induced cell death requires cathepsin B in HeLa cells

(2010) S. Bien et al.   BIOCHEMICAL PHARMACOLOGY

The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy

(2010) Stephen L. Abrams et al.   CELL CYCLE

Homologous RBC-derived vesicles as ultrasmall carriers of iron oxide for magnetic resonance imaging of stem cells

(2010) Microsugar Chang et al.   NANOTECHNOLOGY

Lysosomes in iron metabolism, ageing and apoptosis

(2008) Tino Kurz et al.   HISTOCHEMISTRY AND CELL BIOLOGY